Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

EVANSTON, Ill.--(BUSINESS WIRE)--May 23, 2007 - Northfield Laboratories, Inc. (NASDAQ: NFLD) reported today results of its pivotal Phase III trauma trial with PolyHeme(R), its human hemoglobin-based oxygen-carrying red blood cell substitute. The trial was designed to seek an indication for use in the treatment of life-threatening red blood cell loss when transfusion is required and red blood cells are not available, not for use interchangeably with blood. This indication addresses a critical, unmet medical need.

The primary efficacy endpoint of the study was a dual superiority-noninferiority assessment of mortality at 30 days after injury. The margin to assess noninferiority, using the upper limit of the confidence interval, was set at 7% more than control. In the primary Modified Intent to Treat population, the upper limit was 7.65%. In the As Treated population, the upper limit was 7.06%. In the Per Protocol population, the upper limit was 6.29%.

Day 30 mortality was also a primary safety endpoint. Further analysis of the mortality data indicates that the difference in mortality at 30 days between patients who received PolyHeme beginning at the scene and continuing for up to 12 hours following injury, and control patients who received the standard of care, including early blood, was not statistically significant.

"The results of this study are best understood in the context of bleeding patients who do not have early access to blood transfusion," said Steven A. Gould, M.D., Chairman and Chief Executive Officer. "47 million Americans live more than an hour away from a trauma center where blood is available. Mortality rates in that scenario would be considerably higher than those observed in the control patients in the urban setting of this trial, where transit times were relatively short. We believe that when our data are extrapolated to patients who need an oxygen carrier and have delayed access
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
(Date:1/23/2015)... China , Jan. 23, 2015 Tianyin Pharmaceutical ... company that specializes in the development and sale of ... generics and active pharmaceutical ingredients (API) today announced the ... (JCM) API operation. 1. Following the September ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... announces that a new market research report is available ... Markets and Companies http://www.reportlinker.com/p0203550/Proteomics---Technologies-Markets-and-Companies.html ... describes and evaluates the proteomic technologies that will play ... practice of medicine in the post-genomic era - the ...
... Spain, March 7, 2011 Grifols, a global healthcare ... announced that it has established an Expert Advisory Council ... renowned physicians and researchers from across the globe.  The ... insight, advice and guidance to Grifols, own transfusion medicine ...
Cached Medicine Technology:Reportlinker Adds Proteomics - Technologies, Markets and Companies 2Reportlinker Adds Proteomics - Technologies, Markets and Companies 3Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3
(Date:1/22/2015)... 22, 2015 Joan Lunden, award-winning American ... at the upcoming 32nd Annual Miami Breast Cancer ... Education Resource®, LLC (PER®) , shares that “a fast-growing, ... undetected if she had not followed up her clean ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... ... Care in New York City, has refined an innovative "No-Touch" surgical technique that has caused ... penile implanter are over TWELVE TIMES as high as Dr. Eid,s rate, which is less ... New York, ...
... , ... The Eric Westacott Foundation announced today that it has teamed ... Christopher and Dana Reeve Foundation to donate the proceeds of the upcoming ... from Ohio. The Christopher and Dana Reeve Foundation have also stepped in ...
... ... negotiators with essential information. , ... (PRWEB) July 30, 2009 -- Businesses looking to lease commercial space can easily compare the ... Commercial Real Estate Group of Tucson (CREGT). ,The Lease With Ease calculator offers easy ...
... , ... ovarian cancer therapy; currently none available; Diphtheria-encoding genes delivered to tumor site by nanoparticles; ... ... delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden ...
... , , , ... not just a beautiful place for patients to relax, it is ... and the Agnes and Morland Hamilton Healing Conservatory at Aurora St. ... gold status. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) ...
... , , , ... OSTE ), a leader in the emerging field of biologic products for ... ended June 30, 2009. , , "During the second quarter, ... achievement of our 2009 and 2010 goals," said Sam Owusu-Akyaw, President and Chief ...
Cached Medicine News:Health News:Penile Prosthesis Surgery Infection Rates Reduced With The No-Touch Technique By Dr. J. Francois Eid of Advanced Urological Care 2Health News:Penile Prosthesis Surgery Infection Rates Reduced With The No-Touch Technique By Dr. J. Francois Eid of Advanced Urological Care 3Health News:Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 2Health News:Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 3Health News:Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 4Health News:Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 5Health News:Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options 2Health News:Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth 2Health News:Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth 3Health News:Aurora St. Luke's Healing Garden Earns LEED Certification 2Health News:Osteotech Reports Second Quarter 2009 Financial Results 2Health News:Osteotech Reports Second Quarter 2009 Financial Results 3Health News:Osteotech Reports Second Quarter 2009 Financial Results 4Health News:Osteotech Reports Second Quarter 2009 Financial Results 5Health News:Osteotech Reports Second Quarter 2009 Financial Results 6Health News:Osteotech Reports Second Quarter 2009 Financial Results 7Health News:Osteotech Reports Second Quarter 2009 Financial Results 8Health News:Osteotech Reports Second Quarter 2009 Financial Results 9
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: